DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone...
DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients
About this item
Full title
Author / Creator
Nimmrich, Inko , Sieuwerts, Anieta M. , Meijer-van Gelder, Marion E. , Schwope, Ina , Bolt-de Vries, Joan , Harbeck, Nadia , Koenig, Thomas , Hartmann, Oliver , Kluth, Antje , Dietrich, Dimo , Magdolen, Viktor , Portengen, Henk , Look, Maxime P. , Klijn, Jan G. M. , Lesche, Ralf , Schmitt, Manfred , Maier, Sabine , Foekens, John A. and Martens, John W. M.
Publisher
Boston: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
Boston: Springer US
Subjects
More information
Scope and Contents
Contents
Background
In this study, we evaluated if
PITX2
DNA methylation is a marker for disease recurrence in lymph node-negative (LNN), steroid hormone receptor-positive (HR+) breast cancer patients. In addition, we studied the association between
PITX2
DNA methylation and
PITX2
gene expression.
Patients and methods
PITX2
DNA...
Alternative Titles
Full title
DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients
Authors, Artists and Contributors
Author / Creator
Sieuwerts, Anieta M.
Meijer-van Gelder, Marion E.
Schwope, Ina
Bolt-de Vries, Joan
Harbeck, Nadia
Koenig, Thomas
Hartmann, Oliver
Kluth, Antje
Dietrich, Dimo
Magdolen, Viktor
Portengen, Henk
Look, Maxime P.
Klijn, Jan G. M.
Lesche, Ralf
Schmitt, Manfred
Maier, Sabine
Foekens, John A.
Martens, John W. M.
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_69530746
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_69530746
Other Identifiers
ISSN
0167-6806
E-ISSN
1573-7217
DOI
10.1007/s10549-007-9800-8
